Argentum Logo_RGB2

Dementia Blood Test Debuts This Year

A blood test that can diagnose Alzheimer’s disease with more than 90
percent accuracy will hit the U.S. market as soon as this summer,
according to the Society of Chemical Industry. The test, called NuroPro
and developed by Power3 Medical Products, measures protein biomarkers
in the blood and can also diagnose Parkinson’s disease.

NuroPro is going through clinical validation trials now and first
will be released in Greece before making its way to the U.S. market.
This will be the first commercial diagnostic test available for
diagnosing neurodegenerative diseases.

Stay Connected

Get updates on the latest news impacting senior living through our Argentum Daily newsletter.



Forgot Password
Create an Account